Basic research

Basic research, also called pure research or fundamental research, is scientific research aimed to improve scientific theories for improved understanding or prediction of natural or other phenomena.Applied research, in turn, uses scientific theories to develop technology or techniques to intervene and alter natural or other phenomena. Though often driven by curiosity, basic research fuels applied science's innovations. The two aims are often coordinated in research and development.

Although many discoveries have been serendipitous, discovery science specifically seeks discoveries, and, along with theoretical science and experimental science, is now key to basic research and is sometimes expressly planned.

Overview

Basic research advances fundamental knowledge about the world. It focuses on refuting or supporting theories that explain observed phenomena. Pure research is the source of most new scientific ideas and ways of thinking about the world. It can be exploratory, descriptive, or explanatory; however, explanatory research is the most common.

Basic Research

Basic Research is an herbal supplement and cosmetics manufacturer formed in 1993, based in Salt Lake City, Utah that distributes products through a large number of subsidiaries. In addition, their products are sold domestically and internationally through a number of high-end retailers. Dennis Gay is the president and chief executive officer of Basic Research. Basic Research has also been known to conduct business as Silver Sage (2000), and as The Carter-Reed Company (2002).

On July 10, 2009, the StriVectin family of products [Klein-Becker] were sold to a venture-capital backed company, the Strivectin Operating Company, Inc, to be managed by the Chrysallis Management Group. The new company is based in New York and is not related to Basic Research or any of its affiliates/subsidiaries. The sale affected only the StriVectin products. All other products remained with the Utah-based company.

Relacore, has come under scrutiny by the FDA for making claims that cannot be substantiated or that would place the product under FDA regulation as a drug.